FOLLOW US

  • facebook
  • twitter
Thu

March 12, 2026

Apple Tree filed for Chapter 11

America December 10, 2025

Apple Tree Filed for Chapter 11 Amid $97M Funding Dispute

Biotechnology investor Apple Tree Life Sciences Inc. and affiliated entities filed for Chapter 11 bankruptcy protection in Delaware on Tuesday,…

By Rihem Akkouche

Novartis Buy Avidity Biosciences

America October 27, 2025

Novartis to Buy Avidity Biosciences in $12 Billion Deal

In a bold step that cements its place at the forefront of genetic medicine, Novartis AG announced Sunday that it…

By Rihem Akkouche

Eli Lilly to acquire Adverum Biotechnologies

America October 24, 2025

Eli Lilly to Acquire Adverum Biotechnologies

Pharmaceutical powerhouse Eli Lilly and Co. announced Friday that it will acquire Adverum Biotechnologies, a clinical-stage gene therapy innovator targeting…

By Rihem Akkouche

Ipsen to acquire ImCheck Therapeutics

America October 22, 2025

Ipsen to acquire ImCheck Therapeutics For €1B

In a sweeping expansion of its cancer drug portfolio, global biopharmaceutical powerhouse Ipsen SAS announced Wednesday that it will acquire…

By Rihem Akkouche

Nanyang Biologics To Go Public

America October 2, 2025

Nanyang Biologics To Go Public in $1.5B SPAC Deal

Singapore-based Nanyang Biologics Pte. Ltd. revealed Thursday it will go public in the U.S. via a merger with special purpose…

By Rihem Akkouche

Labcorp DNA Sequencing lawsuit

America September 24, 2025

Labcorp DNA Sequencing Lawsuit Ends in Midtrial Settlement

A high-profile courtroom showdown over DNA sequencing patents has ended abruptly. Labcorp and Natera reached a midtrial settlement in a…

By Rihem Akkouche

Anne Wojcicki 23andMe Buyout offer

America February 24, 2025

Anne Wojcicki Teams Up for 23andMe Buyout Offer

Anne Wojcicki, CEO of 23andMe, has partnered with private equity powerhouse New Mountain Capital to take the pioneering genetic testing…

By Rihem Akkouche

Omega Therapeutics Hits Chapter 11

America February 10, 2025

Omega Therapeutics Hits Chapter 11

Biotechnology company Omega Therapeutics hit Chapter 11 bankruptcy in Delaware on Monday, listing more than $140 million in debt on…

By Rihem Akkouche

Telix Pharmaceuticals Pulls US IPO

America June 14, 2024

Biotech Firm Telix Pharmaceuticals Pulls US IPO

Australian biotechnology firm Telix Pharmaceuticals Ltd., whose U.S. shares were set to debut trading on Friday, canceled plans for an…

By Rihem Akkouche

Elliott Waives BioMarin Board Deal

America April 17, 2024

Elliott Waives BioMarin Board Deal, Quashing Lawsuit

In a dramatic shift in corporate strategy, Elliott Investment Management LP has relinquished an earlier pact with BioMarin Pharmaceutical Inc.,…

By Rihem Akkouche

Signup for the USA Herald
exclusive Newsletter